본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Stamulumab Biosimilar – Anti-MSTN, GDF-8 mAb – Research Grade

Cat-No. PX-TA1144


Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.




제품 설명 


Stamulumab Biosimilar – Anti-MSTN, GDF-8 mAb – Research Grade

  



제품 번호

 

PX-TA1144

 



제품 특징


Product nameStamulumab Biosimilar - Anti-MSTN, GDF-8 mAb - Research Grade
SourceCAS 705287-60-1
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsStamulumab,MYO-029,MSTN, GDF-8,anti-MSTN, GDF-8
ReferencePX-TA1144
NoteFor research use only. Not suitable for human use.
IsotypeIgG1-nd
ClonalityMonoclonal Antibody


Description of Stamulumab Biosimilar - Anti-MSTN, GDF-8 mAb - Research Grade

General information on Anti-MSTN/GDF-8(Homo sapiens) (Stamulumab) Monoclonal Antibody

Stamulumab is an experimental drug that inhibits myostatin and can be used to treat muscular dystrophy (MD). Myostatin is a protein that inhibits the growth of muscle tissue. Stamulumab is a recombinant human antibody targetting and inhibiting the activity of myostatin. It is a G1 immunoglobulin antibody that can bind to myostatin and prevent it from binding to its target site, thereby inhibiting the growth-limiting effect of myostatin on muscle tissue.




QC & Validation Data


SDS-PAGE for Stamulumab Biosimilar - Anti-MSTN, GDF-8 mAb

Stamulumab Biosimilar - Anti-MSTN, GDF-8 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.




Publications


  • Francesca Torrini, Federica Battaglia, Davide Sestaioni, Pasquale Palladino, Simona Scarano, Maria Minunni, Monoclonal antibodies (mAbs) optical detection by coupling innovative imprinted biopolymers and magnetic beads: The case of therapeutic mAb anti-myostatin detection, Sensors and Actuators B: Chemical, Volume 383, 2023, 133586, ISSN 0925-4005, https://doi.org/10.1016/j.snb.2023.133586.




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"